Transducin-Like Enhancer of Split 3 (TLE3) expression is associated with taxane sensitivity in non-serous ovarian carcinoma in a three-cohort study

BACKGROUND: Chemo-resistance is a major challenge in ovarian cancer treatment, resulting in poor survival rates. Identifying markers of treatment response is imperative for improving outcome while minimizing unnecessary side effects. We have previously demonstrated that expression of transducin-like...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Epidemiol Biomarkers Prev
Main Authors: Ring, Brian Z., Murali, Rajmohan, Soslow, Robert A., Bowtell, David D.L., Fereday, Sian, deFazio, Anna, Traficante, Nadia, Kennedy, Catherine J, Brand, Alison, Sharma, Raghwa, Harnett, Paul, Samimi, Goli
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984690/
https://ncbi.nlm.nih.gov/pubmed/29531130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-17-1101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados